Supergut, the trailblazing gut health and GLP-1 nutrition brand, has closed a significant minority growth investment led by Full Frame Growth Partners, signaling its ambition to dominate the $51.6B digestive wellness market.
The funding round, which includes participation from The Production Board, Cultivian Sandbox, and other notable investors, coincides with the appointment of Tracey Warner Halama —former CEO of Vital Proteins—as Supergut ’s new CEO. Founder Marc Washington will transition to Executive
Chairman, focusing on innovation and strategic expansion. Why Investors Are Betting Big on Supergut Explosive Growth: Supergut’s revenue surged 172% in 2024 , fueled by its GLP-1 Booster —a patented prebiotic fiber blend—and expansion into 5,000+ retail doors, including Target, GNC, and Sprouts.
Clinical Evaluation: The brand remains the only gut health company with a gold-standard, peer-reviewed study proving its products reduce cravings, improve blood sugar control, and support weight management.
Megatrend Alignment: Gut health and GLP-1 nutrition are projected to grow at 8.3% CAGR , with Supergut uniquely positioned at their intersection.
Scaling A Mission Driven Brand Halama, who scaled Vital Proteins from $0 to $100M+ before its Nestlé acquisition, brings operational rigor to Supergut’s next chapter: “Supergut has all the makings of a legacy brand—science-backed products, national retail distribution, and a purpose-driven mission…
